BRD-A72024019-001-01-7 (Substance)

Compound:

(Z)-N-[2-(3-acetamido-4,5-dihydroxy-6-methyloxan-2-yl)oxy-6-[2-[5-(2,4-dioxopyrimidin-1-yl)-3,4-dihydroxyoxolan-2-yl]-2-hydroxyethyl]-4,5-dihydroxyoxan-3-yl]-5-methylhex-2-enamide

Compound (Entity type)

Synonyms:BRD-A72024019-001-01-7

Id:177749529

Analyze

CFDE DD-Knowledge Graph

The CFDE Data Distillery Knowledge Graph contains entities and relationships across the CFDE. View BRD-A72024019-001-01-7's neighborhood in the knowledge graph.

Submit

Results found

Linked to

	Label	Description
	L1000 LINCS DCIC 2021 ISO002 MCF10A.EGFR.HL 24H M03 tunicamycin 1.11uM Biosample (Entity type)	A biosample from LINCS produced as part of the LINCS 2021 project
	L1000 LINCS DCIC 2021 MUC.CP008 MCF7 24H M06 tunicamycin 0.04uM Biosample (Entity type)	A biosample from LINCS produced as part of the LINCS 2021 project
	L1000 LINCS DCIC 2021 CPC012 PC3 6H E07 tunicamycin 10uM Biosample (Entity type)	A biosample from LINCS produced as part of the LINCS 2021 project
	L1000 LINCS DCIC 2021 ISO002 MCF10A.KRAS.HG 24H M02 tunicamycin 3.33uM Biosample (Entity type)	A biosample from LINCS produced as part of the LINCS 2021 project
	L1000 LINCS DCIC 2021 ISO002 MCF10A.WTLP 24H M02 tunicamycin 3.33uM Biosample (Entity type)	A biosample from LINCS produced as part of the LINCS 2021 project
	L1000 LINCS DCIC 2021 ISO002 HCT116.TP53.HR 24H M05 tunicamycin 0.125uM Biosample (Entity type)	A biosample from LINCS produced as part of the LINCS 2021 project
	L1000 LINCS DCIC 2021 CPC012 MCF7 6H E07 tunicamycin 10uM Biosample (Entity type)	A biosample from LINCS produced as part of the LINCS 2021 project
	L1000 LINCS DCIC 2021 ISO002 MCF10A.BRCA1.HD 24H M03 tunicamycin 1.11uM Biosample (Entity type)	A biosample from LINCS produced as part of the LINCS 2021 project
	L1000 LINCS DCIC 2021 ISO002 HCT116.TP53.HR 24H M04 tunicamycin 0.37uM Biosample (Entity type)	A biosample from LINCS produced as part of the LINCS 2021 project
	L1000 LINCS DCIC CPC012 A375 6H E07 tunicamycin 10.00um Biosample (Entity type)	A biosample from LINCS produced as part of the L1000 Phase1 project